BlackRock Investment Management’s Sophiris Bio, Inc. SPHS Stock Holding History

BlackRock Investment Management’s Portfolio SPHS Stock Details SPHS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-2,452	Closed	-$1K	–	4328
2015 Q1	$1K	Hold	2,452	–	–	﹤0.01%	4057
2014 Q4	$1K	Hold	2,452	–	–	﹤0.01%	4118
2014 Q3	$7K	Buy	2,452 +949	+63%	+$2.67K	﹤0.01%	3836
2014 Q2	$3K	Buy	+1,503	New	+$4.45K	﹤0.01%	3986

Other funds holding SPHS

GCM

Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock Investment Management's SPHS Position: Q2 2015 in Review

BlackRock Investment Management sold out of Sophiris Bio, Inc. (SPHS) in Q2 2015, closing a stake of 2,452 shares — an estimated $1K sold.

BlackRock Investment Management first reported a position in SPHS in Q2 2014 and held it in 4 quarters. The position peaked at $7K in Q3 2014. 18 funds tracked by Wall St. Rank hold SPHS as of Q2 2015.

BlackRock Investment Management reported no remaining Sophiris Bio, Inc. position as of Q2 2015 after selling out during the quarter.
BlackRock Investment Management sold 2,452 Sophiris Bio, Inc. shares in Q2 2015, an estimated $1K.
BlackRock Investment Management first reported a position in Sophiris Bio, Inc. in Q2 2014 and held it in 4 quarters.
BlackRock Investment Management's Sophiris Bio, Inc. position peaked at $7K in Q3 2014.
18 funds tracked by Wall St. Rank held Sophiris Bio, Inc. as of Q2 2015.

Based on BlackRock Investment Management's 13F filing for Q2 2015, filed 7 Aug 2015.